Graphite Bio: Jane Grogan
Graphite Bio has appointed Jane Grogan, Ph.D., as its Chief Scientific Office and member of the company’s executive leadership team.
The company is a clinical-stage, next-generation gene editing company, harnessing high efficiency targeted gene integration to develop a new class of therapies.
Dr. Grogan is a renowned scientist in the fields of immunology, oncology and cell therapy with over two decades of biotech and life sciences industry experience, including a tenure of more than 15 years at Genentech advancing programs from discovery biology and target identification through to late-stage clinical development and approval.
At Graphite Bio, Dr. Grogan will apply this extensive relevant experience to lead robust research efforts, leverage the company’s targeted gene integration platform technology in new therapeutic areas to impact patients and guide the continued growth of the company’s world-class research group. She will also play a critical role in advancing research of targeted and safer bone marrow conditioning regimens to improve and expand the applications and impact of Graphite Bio’s hematopoietic stem cell therapies for patients with serious diseases.
Immediately prior to joining Graphite Bio, she served as Chief Scientific Officer and a member of the executive leadership team at ArsenalBio, a programmable cell therapy company, where she established the research organization and preclinical pipeline of cell therapies for solid tumors.
From 2004-2019, Dr. Grogan worked at Genentech, a member of the Roche Group. As head of adaptive tumor immunity and principal scientist of cancer immunology discovery research, she oversaw discovery research programs from idea and target identification through clinical development, and managed in-licensing business partnerships and external development collaborations.
During her career, Dr. Grogan has published over 60 papers in a wide array of journals and is the inventor on over 20 patents. She obtained her Ph.D. from Leiden University, The Netherlands, and her BSci (Hons) degree from the University of Melbourne, Australia. Dr. Grogan completed her post-doctoral training as an Alexander von Humboldt Fellow at the German Rheumatism Research Centre Berlin (DRFZ) and as a Howard Hughes Fellow at the University of California, San Francisco (UCSF).
Dr. Grogan is also known as the founder and original host of the popular podcast series "Two Scientists Walk into a Bar.”
